Home > Patient Educational Videos > Lung Cancer - Treatment of Stage 4 Metastatic Non Small Cell Lung Cancer

Treatment of Stage 4 Metastatic Nonsmall Cell Lung Cancer


Lung cancer is the most common cancer worldwide, with an estimated 1,600,000 new cases and 1,380,000 deaths in 2008. In the United States, there will be an estimated 221,000 new cases of lung cancer and 157,000 deaths in 2010.

The term lung cancer, or bronchogenic carcinoma, refers to malignancies that originate in the airways or pulmonary parenchyma. Approximately 95 percent of all lung cancers are classified as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC). This distinction is essential for staging, treatment, and prognosis. Other cell types comprise about 5 percent of malignancies arising in the lung.

A number of environmental and life-style factors have been associated with the subsequent development of lung cancer, of which cigarette smoking is the most important.   Other Environmental factors have been associated with an increased risk for developing lung cancer. These include exposure to second-hand smoke, asbestos, radon, ionizing radiation, and polycyclic aromatic hydrocarbons.

The World Health Organization classification for primary lung cancer recognizes four major histologic cell types:

     1-Adenocarcinoma (including bronchioloalveolar carcinoma) 
     2-Squamous cell carcinoma 
     3-Large cell carcinoma
     4-Small cell carcinoma 

Here, Dr. Tony Talebi discusses the treatment of stage 4 metastatic non-small cell lung cancer with Dr. Jorge Gomez including the symptoms and signs of lung cancer, diagnosis with endobronchial ultrasound guided biopsy, staging with CT scan or PET scan, other imaging modalities, genetic implications and treatment of metastatic stage 4 non small cell lung cancer including options of surgery, radiation therapy and chemotherapy including new biologic treatments bevacizumab (Avastin), cetuximab (Erbitux), erlotinib (Tarceva), and EGFR overexpression in lung cancer, lung cancer prognosis, what causes lung cancer, signs of lung cancer, lung cancer symptoms, lungs cancer, lung cancer stage 4, treatment of lung cancer, lung cancer association, stage four lung cancer, small cell lung cancer, symtoms of lung cancer, causes of lung cancer, lung cancer chemotherapy, what is lung cancer, lung cancers, lung cancer information, lung cancer prevention, stage 4 lung cancer, information about lung cancer, stage iv lung cancer, lung cancer signs, lung cancer symptom, is lung cancer curable, stage 3b lung cancer, lungs cancer symptoms, survival rates for lung cancer, symptoms of lung cancer, lung cancer survivors, lung cancer symptons, lung cancer survival, treatments of lung cancer, symptons of lung cancer, lung cancer statistics, non small cell lung cancer, chemo for lung cancer, lung cancer survival rate, large cell lung cancer, effects of lung cancer, lung cancer screening, lung cancer diagnosis, lung cancer societ lung cancer clinical trials, lung cancer metastasis, survival rate lung cancer, symptom of lung cancer, info on lung cancer, new treatments for lung cancer, how common is lung cancer.

.

Dr. Jorge Gomez credentials:

Certifications                   American Board of Internal Med-Medical Oncology

Specialties

  • Hematology/Oncology - Internal Medicine
  • Internal Medicine

Roles

  • Assistant Professor of Clinical Medicine
  • University of Miami Sylvester Comprehensive Cancer Center

Clinical Interests

Non-small cell lung cancer

Small cell lung cancer

Research Interests

Non-small cell lung cancer

Small cell lung cancer

Lung cancer in young adults

Education

2001 Fellowship
New York University School of Medicine
1997 Residency
Pennsylvania Hospital
1995 Internship
Pennsylvania Hospital